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Abstract
Background: Children and adolescents with Juvenile Idiopathic Arthritis (JIA) typically have reduced physical
activity level and impaired aerobic and anaerobic exercise capacity when compared to their non-JIA counterparts.
Low intensity exercise regimens appear to be safe in children with JIA and may results in improvements in overall
physical function. Poor adherence to paediatric rheumatology treatment may lead to negative clinical outcomes
and possibly increased disease activity. This includes symptoms such as pain, fatigue, quality of life, longer term
outcomes including joint damage, as well as increase of healthcare associated costs. Low adherence to medications
such as methotrexate and biological-drugs remains a significant issue for paediatric rheumatologists, with alarming
reports that less than half of the children with JIA are compliant to drug-therapy.
Main body: The recent advances in interactive technology resulting in a variety of wearable user-friendly smart
devices may become a key solution to address important questions in JIA clinical management. Fully
understanding the impact that arthritis and treatment complications have upon individual children and their
families has long been a challenge for clinicians. Modern interactive technologies can be customised and accessed
directly in the hands or wrists of children with JIA. These secured networks could be accessible ‘live’ at anytime and
anywhere by the child, parents and clinicians.
Multidisciplinary teams in paediatric rheumatology may benefit from adopting these technologies to better
understand domains such as patient biological parameters, symptoms progression, adherence to drug-therapy,
quality of life, and participation in physical activities. Most importantly the use of smart devices technologies may
also facilitate more timely clinical decisions, improve self-management and parents awareness in the progression of
their child’s disease. Paediatric rheumatology research could also benefit from the use of these smart devices, as
they would allow real-time access to meaningful data to thoroughly understand the disease-patterns of JIA, such as
pain and physical activity outcomes. Data collection that typically occurs once every 1 or 3 months in the clinical
setting could instead be gathered every week, day, minute or virtually live online. Arguably, few limitations in
wearing such interactive technologies still exist and require further developments.
Conclusion: Finally, by embracing and adapting these new and now highly accessible interactive technologies,
clinical management and research in paediatric rheumatology may be greatly advanced.
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Background
Juvenile Idiopathic Arthritis (JIA) incurs a significant
burden to patients, their families, and the community
[1]. Children with JIA may experience significant issues
with school attendance that has a direct impact on their
academic performance [2, 3]. Hospitalisation rates in
Australia for juvenile arthritis have increased from 14 to
32 per 100,000 population over the past decade [1]. A
sharp 118% rise in allied health professional (AHP)
involvement has also been recorded in Australia since
2005, including specialist nurses, occupational therapists,
physiotherapists, and podiatrists [1]. Some of the pre-
scribed not invasive interventions from AHP, such as
regular physical exercises, could be increasingly self-
managed by the child and their families and carried out
without the need of attending clinics and hospitals,
which may positively impact the child’s school attend-
ance. Thus, we feel that recent advances in technology
resulting in a variety of wearable user-friendly smart de-
vices, capable of providing customised notifications, may
become a key instrument in JIA clinical management.
Furthermore, data collection and incorporating patient
reported outcomes through interactive technologies,
may play a significant role in health promotion and self-
management of disease into the future [4].
Monitoring symptoms and disease progression using
interactive technologies
Understanding the impact that chronic disease and treat-
ment complications have upon children and their families
has long been a challenge for clinicians. Typically, practi-
tioners are unable to undertake frequent assessment and
so most measures, such as quality of life and disease pro-
gression, rely on recall during appointments.
A number of successful attempts have already been
made in introducing smart devices to better understand
patients’ disease, particularly in paediatric oncology,
chronic pain, and allergic disease [5, 6]. Cingi et al.
(2015), investigated 327 patients diagnosed with mild-to-
severe persistent asthma and persistent allergic rhinitis
(AR) that were randomised into 2 intervention groups
and 2 control groups using a smart mobile platform
called POPET. The intervention groups (POPET-AR and
POPET-Asthma) received a mobile phone application
(“physician on call patient engagement trial” [POPET]),
enabling them to interact with their clinicians, and inde-
pendently record their health status and compliance to
their prescribed drugs. Those using the online platform
had better health outcomes and quality of life, with a
reduction in hospital admissions and number of medical
consultations required. Furthermore, improvements were
also recorded with regards to activity, productivity, disease
perception, and emotion status. Stinson et al. (2015)
investigated the validity, reliability, and feasibility of a
smartphone pain assessment app among 106 children and
adolescent diagnosed with cancer, and concluded that the
app had excellent internal consistency, feasibility, and an
overall high acceptability amongst patients.
Children and young people with JIA require active in-
volvement in their own health decision-making and life-
style management [7]. Pilot programs in adult rheumatic
disease and other chronic health conditions have already
identified the use of modern technology as a possible
strategy to improve self-management; however, large
scale studies specifically in JIA are still pending [8–10].
The feasibility of online self-assessment system has been
performed over a 3-month period using a smart-phone
application in only 9 Japanese Rheumatic Arthritis (RA)
patients [8]. The smart app provided daily notifications
and comments related to the disease activity [8]. The
size of this study was very small and 89% of patients
were women; however, the results indicated that the
app was capable of longitudinally predict the disease
activity score in RA patients and it may be an accept-
able and useful tool for both patients and healthcare
providers [8].
Jongh et al. (2012) published a Cochrane systematic
review including four randomised controlled trials, in-
volving 182 participants diagnosed with diabetes, hyper-
tension and asthma. The studies investigated whether
mobile phone App, including SMS and MMS, were able
to improve self-management by providing medication
reminders or supportive notifications to patients to
communicate important information to their healthcare
providers and exchanged prompt feedback [9]. Although
the authors reported that longer studies and larger
sample sizes are still necessary, overall moderate quality
evidence was found suggesting positive impacts on the
health of patients [9].
Majeed-Ariss et al. (2015) conducted a Systematic
Review of Adolescents’ Use of Mobile Phone and Tablet
Apps that Support Personal Management with their
Chronic or Long-Term Physical Conditions. It included
4 papers and 46 participants with type 1 diabetes,
asthma, and cancer. The authors concluded that smart
devices represent a feasible health intervention; however,
larger studies are still required in order to determine the
Apps’ acceptability and effectiveness [10].
Adherence to prescribed medications
Adherence to the prescribed treatment is essential so
that children with JIA do not continue to endure joint
symptoms, fatigue, reduced physical activity level and
lower quality of life [11] and also to avoid rise of health-
care costs through increased frequency of consultations
and diagnostic tests [1].
Adherence to medications including methotrexate and
biological-drugs remains a significant issue in paediatric
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rheumatology, with alarming reports that as few as 53%
of children with rheumatic disease (RD) have good
overall drug-adherence [12]. Bugni et al. (2012) reported
that 20 children with RD, equivalent to 20.2% of the
participant recruited, had poor medication adherence
related to the use of three or more daily medications
(p = 0.047). Specifically to children with JIA, 28(51%)
patients were not adherent to the prescribed medication
[12]. Pelajo et al. (2012) investigated 76 outpatients and
the overall rate of non-adherence to methotrexate was
18% amongst American and Portuguese children with
JIA, between 1 and 17 years old. The rate of reported
non-adherence was 8% in Boston and 24% in Rio de
Janeiro (P = 0.012) [13]. Interestingly, the main reason
for non-adherence in Boston was “child refused”, while
in Rio de Janeiro non-adherence was mostly related to
an inability to acquire the medication [13]. Multiple rea-
sons should be considered when addressing medication
adherence, such as child refusal, adverse effects or lack
of medication availability, personal issues, and financial
hardship [12]. Another major reason for adherence fail-
ure is forgetfulness [12]; therefore, in order to encourage
children to take their prescribed drugs, parents/carers are
often essential to ensuring adherence. It is possible that
smart reminders, accessible directly from the patient’s
mobile or tablet, may assist medication adherence.
Research in adolescents with asthma has suggested
that interactive technologies should be explored as a
means of improving medication adherence [14] including
customised reminders accessible through a smartphone
app and online information [15]. A similar approach, to
test medication adherence, was successfully introduced by
Crosby et al. [16] in 43 children and adolescents (age
range 6–21) with sickle cell disease (SCD) showing 90%
satisfaction with patients. This data highlights the poten-
tial to integrate smart web-based technology into paediat-
ric clinical care.
Encouraging physical activity
Children with JIA typically have reduced physical activity
levels when compared to their non-JIA counterparts
[11]. Poor aerobic capacity and low activity detected in
children and adolescents with JIA represent a significant
clinical concern, as it is likely that the reduced fitness
levels will then impact their adulthood [11, 17]. Physical
activity is safe in JIA and may results in improvements
in physical function [18]. Thus encouraging physical
activity in children with JIA is likely to have a beneficial
effect. In an age where exercise in children is falling
[19], the paediatric rheumatology multidisciplinary team
should explore new interactive technologies to increase
physical activity adherence.
Modern interactive technologies can be individualised
and accessed directly in the hands or on the wrists of
children with JIA. Information gathered by smart-
watches (or wristbands) that are worn throughout the
day by the child, already has the capacity to be wirelessly
connected via Cloud networks to databases that collate
physical activity data for individual and group analysis.
These secured networks could be accessible ‘live’ at any-
time and anywhere by the child, parents and clinicians
and allow multidisciplinary teams to better understand
domains such as physical activity and energy expend-
iture. This technology has the potential to facilitate more
timely clinical decisions; improve self-management and
parent’s awareness in the progression of their child’s
exercise level and physical activity targets.
Smart devices can provide real-time biofeedback; the
inbuilt accelerometers and heart rate monitors can
measure physical activity intensity, while GPS can be
employed to precisely monitor distance of movement
throughout the day. As soon as the daily, weekly and/or
monthly activity target has been achieved, the child with
JIA could be informed (for example with a gentle vibra-
tion on the wrist) and recorded for their achievements
through messages or ‘awards icons’ directly on their
watch screen. These ‘award icons’ may serve as incentive
and positive reinforcement for participating in a custo-
mised management plan, with the ultimate goal of encour-
aging the child with JIA to be more active and healthier.
Future research should investigate the long-term impact
of the positive reinforcements and notifications delivered
by the smart devices, and possibly develop new methods
to promote and sustain long term effectiveness of the
interactive technologies.
Access to interactive technologies
Today’s children and young adults already have accessible
technology integrated into many aspects of their daily life
[20]. They are usually comfortable with smart devices,
which may engage and motivate them more effectively than
traditional methods such as paper-diaries or checklists.
The rapid growth in personal technology such as tab-
lets, smart-phones, and so on, is clearly reflected in daily
usage amongst children and adolescents. In 2010, for
example, 15% of teenagers in Australia owned a smart-
phone; and by 2013 users sharply increased to 69% of
this population [20]. As smartphones are becoming
more accessible and affordable, the number of young
consumers is expected to continue growing such that in
Australia most adolescents and many younger children
are likely to have access to and use smart devices on a
regular basis in the future.
Potential new approach to paediatric rheumatology
management
With the introduction of already existing interactive tech-
nologies as part of the routine paediatric rheumatology
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care, we feel that new safe and cost effective approaches
to care may be possible. Clinicians could connect with the
child or family members by providing discreet reminders
to inform that a medication is due or if symptom report-
ing is required. With a simple ‘tap’ on the smart-watch (or
wrist band), the child could confirm when the drug was
administered. Similarly, pain levels, physical activity and
quality of life data may be recorded weekly, daily or even
in real time. Data could be transferred to a secure ‘Cloud
Platform’ for analysis and accessed by patients, their fam-
ilies and clinicians as appropriate. The child with JIA may
benefit also from receiving personalised notifications such
as text messages, from the clinicians with the aim of pro-
moting positive behavioural changes and encourage daily
self-management. The data collected may also facilitate
the child, their family and the clinicians to become more
aware of disease patterns (Fig. 1).
Data collection that currently occurs once every 1 or
3 months in the clinical setting could instead be gathered
constantly and effortlessly, requiring minimal patient and
clinician input. In addition to the ‘Cloud Platform’, data
could also be used to develop logarithms to predict poor
outcomes and allow immediate intervention; or foresee
early flares of disease and instigate prompt interventions
to minimise disruption to the patient’s daily life. This new
interactive and user-focussed approach has the potential
to significantly increase both the child’s and family’s en-
gagement in their care. The introduction of smart devices
to paediatric rheumatology care may provide meaningful
improvements in clinical outcomes, patient well-being
and engagement, with possible cost reductions for the
health care system.
Data protection and limitations
While protecting patient privacy and confidentiality of
data remains paramount, many appropriate security
protocols already exist amongst the major smart device
providers, such as Google™ [21] and Apple™ [22] to
ensure constant system security, encryption and data
protection, data backup and privacy control, locations
services, passwords authentication and intrusion detec-
tion. Privacy remains a primary concern for patients,
parents and clinicians, especially when it is unclear
where the central warehousing of data is installed, who
owns the data, and who is responsible for the cost asso-
ciated with these technologies.
Arguably, there are still challenges in utilising these
interactive technologies, such as: the need of evidence
regarding feasibility and validity of the apps being
utilised and the need for regular software updates by
service providers or hospital IT departments, that may
impact the reliably of synchronised data transfer. In
addition, missing physical activity data may occur during
sports such as swimming, when wearing smart watches
and wristbands might damage the device. More evidence
is required to establish the willingness of children with
JIA in interacting with health-related technologies espe-
cially at younger age, where children may still exhibit
reading difficulties. Finally, these smart technologies
might generate few unintended consequences such as
increased anxiety, data hyper-vigilance and obsessive
tendency in outcome such as physical activity; which
need to be monitored by healthcare professionals and
family members.
Conclusion
Clearly further studies in paediatric rheumatology are
required to critically evaluate the effectiveness and
acceptability of available apps in large number of
patients and to develop effective apps utilizing valuable
input and feedback from patients, carers and clinicians.
Overall, by embracing and adapting these new and now
highly accessible interactive technologies, clinical man-
agement and research progress in paediatric rheumatol-
ogy could be greatly advanced.
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